Select your location to view local American Lung Association events and news near you.

The COPD therapeutics market presents opportunities in integrated care and digital advancements. Rising disease prevalence ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.

Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled ...

Hayley Burgess SVP, Inovalon, talks about how pharmacies preserve efficiency while strengthening patient care by using ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

Quantitative CT in AATD linked airway wall thickening and bronchiectasis to lung function, while wall thickness best ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

"2025 was a year that demonstrated Bambusa's execution-first culture," said Dr. Xu. "With multiple clinical programs advancing in parallel, we are entering 2026 positioned to deliver up to 10 clinical ...